Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Mar 2026 07:00 AM
RNS
Preliminary results for the year ended 31 Dec 2025
18 Mar 2026 07:00 AM
RNS
Licensing agreement with VVMF
12 Mar 2026 12:25 PM
RNS
Form 8.3 - Oxford Biomedica plc - Amendment
09 Mar 2026 07:53 AM
RNS
Admission to Trading
04 Mar 2026 11:45 AM
RNS
Admission to Trading Application
03 Mar 2026 07:00 AM
RNS
Capital Markets Day and investor conferences
02 Mar 2026 07:00 AM
RNS
Total Voting Rights
27 Feb 2026 01:31 PM
RNS
Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26 Feb 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
26 Feb 2026 01:49 PM
RNS
Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26 Feb 2026 12:33 PM
RNS
Form 8.3 - Oxford Biomedica plc
26 Feb 2026 11:09 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
26 Feb 2026 11:08 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
26 Feb 2026 09:42 AM
RNS
Form 8.5 (EPT/NON-RI) Oxford Biomedica plc
25 Feb 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
25 Feb 2026 02:32 PM
RNS
Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
25 Feb 2026 12:33 PM
RNS
Response to Rule 2.8 Announcement
25 Feb 2026 12:12 PM
RNS
Disclosure Table
25 Feb 2026 12:00 PM
RNS
Rule 2.8 Announcement
25 Feb 2026 11:46 AM
RNS
Form 8.3 - Oxford Biomedica plc
25 Feb 2026 10:53 AM
RNS
Form 8.5 (EPT/NON-RI) Oxford Biomedica Plc
25 Feb 2026 10:17 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
25 Feb 2026 10:15 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
24 Feb 2026 07:29 AM
RNS
Form 8.5 (EPT/RI)-Oxford Biomedica plc
24 Feb 2026 07:25 AM
RNS
Form 8.5 (EPT/NON-RI)-Oxford Biomedica plc
24 Feb 2026 07:03 AM
RNS
Full year Trading Update and Notice of Results
23 Feb 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
23 Feb 2026 02:20 PM
EQS
Form 8.3 - The Vanguard Group, Inc.: Oxford B...
23 Feb 2026 07:40 AM
RNS
Form 8.5 (EPT/RI)-Oxford Biomedica plc
23 Feb 2026 07:39 AM
RNS
Form 8.5 (EPT/NON-RI)-Oxford Biomedica plc
20 Feb 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
20 Feb 2026 01:46 PM
RNS
Form 8.3 - Oxford Biomedica Plc
20 Feb 2026 08:13 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
20 Feb 2026 08:08 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
19 Feb 2026 02:39 PM
RNS
Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
19 Feb 2026 09:44 AM
RNS
Rule 2.9 Announcement
19 Feb 2026 08:04 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
19 Feb 2026 07:54 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
18 Feb 2026 03:20 PM
RNS
Form 8.3 - Oxford Biomedica plc
18 Feb 2026 02:37 PM
RNS
Form 8.3 - Oxford Biomedica Plc
18 Feb 2026 09:32 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
18 Feb 2026 09:18 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
17 Feb 2026 10:21 AM
RNS
Form 8.5 (EPT/NON-RI) Oxford Biomedica Plc
17 Feb 2026 10:15 AM
RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc
17 Feb 2026 10:11 AM
RNS
Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
16 Feb 2026 03:15 PM
RNS
Form 8.5 (EPT/RI)- Replacement of Oxford Biomedica
16 Feb 2026 02:53 PM
RNS
Form 8.3 - Oxford Biomedica Ltd
16 Feb 2026 02:51 PM
RNS
Form 8.3 - Oxford Biomedica Plc
16 Feb 2026 02:27 PM
EQS
Form 8.3 - The Vanguard Group, Inc.: Oxford B...
16 Feb 2026 01:35 PM
RNS
Form 8.3 - Oxford Biomedica plc

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings